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During the first trimester of pregnancy the decidua is comprised of decidual stromal cells 23 
(DSC), invading fetal trophoblast cells and maternal leukocytes, including decidual natural 24 
killer (dNK) cells and macrophages. dNK cells are distinct from peripheral blood NK cells and 25 
have a role in regulating trophoblast invasion and spiral artery remodelling. The unique 26 
phenotype of dNK cells results from the decidual environment in which they reside, however 27 
the interaction and influence of other cells in the decidua on dNK phenotype is unknown. We 28 
isolated first trimester DSC and decidual macrophages and investigated the effect that DSC 29 
and decidual macrophage secreted factors have on CD56+ decidual lymphocyte receptor 30 
expression and cytokine secretion (including dNK cells). We report that DSC secreted factors 31 
induce the secretion of the cytokines IL-8 and IL-6 from first trimester CD56+ cells. However, 32 
neither DSC nor decidual macrophage secreted factors changed CD56+ cell receptor 33 
expression. These results suggest that secreted factors from DSC influence CD56+ decidual 34 
lymphocytes during the first trimester of pregnancy and therefore may play a role in regulating 35 
the unique phenotype and function of dNK cells during placentation.  36 
 37 
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1. Introduction  46 
In the first trimester of pregnancy the decidua is rich with maternal leukocytes, made up of 47 
decidual NK (dNK) cells, decidual macrophages, T cells, a small number of B cells and 48 
dendritic cells and other innate lymphoid cells (ILCs) (Bulmer and Johnson, 1984, Bulmer et 49 
al., 1991, Vacca et al., 2015). In the post-ovulatory mid-secretory phase of the menstrual cycle 50 
decidualisation recruits NK cells to the uterus and local proliferation occurs (Sojka et al., 2018). 51 
This cell population reaches a peak in the late secretory phase and continues to accumulate in 52 
pregnancy, comprising 70% of the decidual leukocyte population by the end of the first 53 
trimester (King et al., 1998, Kopcow et al., 2010). dNK cells are distinct from their peripheral 54 
blood (pb) counterpart, however their function in pregnancy is still largely unknown. dNK cells 55 
have been implicated in regulating key processes at the maternal-fetal interface, including 56 
spiral artery remodelling and extravillous trophoblast (EVT) invasion (Hanna et al., 2006, 57 
Wallace et al., 2012).  58 
dNK cells differ from pbNK cells as they exhibit a CD56bright CD16-CD160- phenotype and 59 
express a unique repertoire of both activating and inhibitory receptors, with increased 60 
expression of CD9, CD69, ILT2, NKp46, NKp44 and NKp30 and the KIR receptors compared 61 
to pbNK cells (Searle et al., 1999, Moffett-King, 2002, Koopman et al., 2003, El Costa et al., 62 
2009). dNK cells have a predominantly cytokine secreting role, rather than the traditional 63 
cytotoxic function displayed by pbNK cells. dNK cells secrete an array of cytokines, including 64 
IL-8 and CXCL10 and angiogenic growth factors, including VEGF and PLGF (Hanna et al., 65 
2006, Wallace et al., 2013c).  66 
During the first trimester of pregnancy, cytotrophoblast cells differentiate into invasive EVT 67 
cells. These EVTs migrate from the cell columns of anchoring placental villi and invade the 68 
maternal decidua and spiral arteries, reaching the inner third of the myometrium by the second 69 
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trimester. During this process spiral arteries are remodelled, EVTs replace endothelial cells and 70 
vascular smooth muscle cells, modifying the arteries from low-flow, high-resistance into high-71 
flow, low-resistance vessels with an increased diameter to ensure the increasing demands of 72 
the fetus are met. Decidual leucocytes, including dNK cells and macrophages, appear in the 73 
decidua prior to EVT and are therefore believed to contribute to initiating the remodelling 74 
process (Smith et al., 2009).  75 
The main cellular component of the decidua is made up of DSC; epithelial-like cells that are 76 
transformed during decidualisation. This process commences after ovulation in the mid-77 
secretory phase of the menstrual cycle, due to rising levels of progesterone. Decidualisation 78 
promotes morphological and biochemical changes to the spindle-shaped fibroblast-like 79 
endometrial cells converting them into secretory DSC. Two major secretory products of the 80 
DSC are IGFBP-1 and prolactin (PRL), classical markers of decidualisation (Gellersen and 81 
Brosens, 2003). However DSC also produce a myriad of other factors, including cytokines, 82 
chemokines, growth factors, angiogenic factors and hormones (Dimitriadis et al., 2005, Engert 83 
et al., 2007). It is these factors that have been implicated in a number of roles, including 84 
immune cell recruitment and activation as well as EVT migration and invasion (Pijnenborg, 85 
1998, Kitaya et al., 2000, Verma et al., 2000, Zhu et al., 2009, Godbole and Modi, 2010). 86 
Decidual macrophages make up the second largest population of leukocytes in the decidua. 87 
They are characterised by their CD14+ phenotype, however, do not fit in to the conventional 88 
M1/M2 macrophage classification. Gene expression profiling suggests that they are skewed 89 
towards a M2 alternatively activated phenotype (Gustafsson et al., 2008). Houser and 90 
colleagues have demonstrated that decidual macrophages consist of two distinct populations 91 
identified by their expression of CD11c, either high (CD11cHI) or intermediate (CDllcLO) 92 
expression, which secrete both pro- and anti-inflammatory cytokines (Houser et al., 2011). 93 
Decidual macrophages have been implicated in establishing local immune balance, EVT 94 
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invasion and spiral artery remodelling (Bulmer et al., 1991, Smith et al., 2009, Hazan et al., 95 
2010, Svensson-Arvelund et al., 2015, Lash et al., 2016).   96 
The unique phenotype of dNK cells results from the decidual environment in which they reside, 97 
which comprises of maternal DSC and immune cells, and the various factors they secrete. In 98 
the present study we have used first trimester DSC and decidual macrophage conditioned media 99 
to investigate the effect that secreted factors from these cells have on CD56+ decidual 100 
lymphocyte receptor expression and cytokine production. We hypothesise that DSC and 101 
decidual macrophage secreted factors will regulate receptor expression and cytokine 102 
production. We provide evidence that DSC secreted factors induce the production of the 103 
cytokines IL-6 and IL-8 from first trimester CD56+ cells; suggesting that DSC influence the 104 
function of dNK cells during early pregnancy.  105 
2. Materials and methods  106 
2.1. DSC isolation  107 
Decidual tissue from 6-13 weeks of gestation was isolated from the products of conception 108 
obtained at termination of pregnancy. Decidual tissue was sorted from placental tissue by 109 
morphology in a petri dish, minced and digested in serum free M199 media containing 4kU 110 
DNase (Sigma Aldrich, UK) and 10kU collagenase (Gibco/ThermoFisher Scientific, 111 
Massachusettes, USA) overnight, at room temperature with agitation/rolling. The digested 112 
decidua was passed sequentially through 100 and 70 µm filters and layered onto Ficoll-Paque 113 
(GE Healthcare, Buckinghamshire, UK) and centrifuged at 710g for 20 minutes. The cells in 114 
the ‘buffy layer’ were collected and washed in RPMI 1640 with 10% (v/v) fetal calf serum 115 
(FCS) supplemented with 2mM L-glutamine (Sigma Aldrich), penicillin (1 unit/ml)/ 116 
streptomycin (100μg/ml; Sigma Aldrich) and amphotericin B (2.5μg/ml; Sigma Aldrich) and 117 
centrifuged. The supernatant was discarded, and the pellet resuspended in red blood cell lysis 118 
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buffer (155mM ammonium chloride (VWR, Leicestershire, UK), 9.9mM Trizma base (Sigma 119 
Aldrich), pH 7.4), incubated for 5 minutes at room temperature, washed in PBS and 120 
centrifuged. The pellet was resuspended in 20ml RPMI media with 10% (v/v) FCS and plated 121 
out for stromal cells to adhere to the bottom of the plate/flask. After approximately 15 minutes, 122 
non-adherent immune cells were removed. Cells were washed in PBS and cultured in DSC 123 
media at 37°C humidified atmosphere, 5% CO2 in air.  124 
2.2. CD56+ cell isolation  125 
CD56+ lymphocytes (including dNK cells) were isolated, as previously described (Wallace et 126 
al., 2013c). In brief, non-adhered immune cells, containing the dNK cell fraction, from DSC 127 
isolation were purified by use of negative selection with a MagCellect Human NK Cell 128 
Isolation Kit (R&D Systems, Abingdon, UK), according to manufacturer’s instructions. Purity, 129 
as measured by CD56+ cells, was 95.26% ± 0.73% (mean ± SEM, n=19), and viability, 130 
immediately upon isolation, was 87.3% ± 1.86% (mean ± SEM, n=19), as assessed by fixable 131 
viability dye (eBioscience, Hatfield, UK).  132 
2.3. Decidual macrophage isolation  133 
Decidual tissue was sorted, minced, digested and filtered the same as above. The filtered 134 
decidual digest was resuspended in 20 ml 15% (v/v) Percoll® (Sigma Aldrich). Percoll cell 135 
suspension was layered on to a Percoll gradient of 5 ml 68% (v/v) and 12.5 ml 45% (v/v) 136 
Percoll and centrifuged for 700g for 30 minutes at 4°C. The cells between the 15% and 45% 137 
Percoll gradient were collected, centrifuged and resuspended in Phenol Red Free RPMI 1640 138 
supplemented with 10% (v/v) FCS, filtered through a 40µm filter, cell number counted, and 139 
cells centrifuged at 500g for 5 minutes. Cells were resuspended in 80µl MACS buffer (PBS 140 
with 0.5% (w/v) BSA (Sigma Aldrich), 2mM EDTA (Sigma Aldrich), adjusted to pH7.2) per 141 
107cells and 20µl anti-CD14 antibody coated magnetic beads (Miltenyi Biotec, Surrey, UK) 142 
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per 107 cells, after 15 minutes incubation at 4°C the cells were centrifuged at 300g for 10 143 
minutes at 4° to prevent loss of beads. The cell pellet was resuspended in MACS buffer and 144 
loaded onto a Large Cell Column with a flow resistor (Miltenyi Biotec) in a magnetic field of 145 
a MiniMACS separator (Miltenyi Biotec), cells not bound to the magnetic beads were removed 146 
by three washes with 500µl MACS buffer. 2ml of MACs buffer was added to the column, the 147 
column was removed from the magnet and the flow resistor removed, then the CD14+ cells 148 
were flushed with the plunger. Cells were centrifuged at 500g for 5 minutes and resuspended 149 
in phenol red free RPMI 1640 supplemented with 10% (v/v) FCS at 1×106 cells/ml. 150 
Immediately after isolation purity, as measured by CD14+ cells, was 72.26% ± 1.8% (mean ± 151 
SEM, n=91) and viability, as assessed by fixable viability dye, was 85.22% ± 1.41% (mean ± 152 
SEM, n=69). Conditioned media (CM) was collected after 6 hours of culture and centrifuged 153 
at 3000g for 5 minutes. The supernatant was stored at -20°c until use. 154 
2.4. Cell culture conditions  155 
Isolated DSC were cultured in DSC medium: RPMI 1640 (Sigma Aldrich) containing 2mM L-156 
glutamine, penicillin (1 unit/ml)/ streptomycin (100μg/ml) and amphotericin B (2.5μg/ml) 157 
supplemented with 10% (v/v) FCS. CD56+ cells were cultured in dNK medium: Phenol Red 158 
Free RPMI 1640 supplemented with 10% (v/v) FBS, 50ng/ml stem cell factor (SCF; Peprotech, 159 
London, UK) and 5ng/ml IL-15 (Peprotech), containing 2mmol/L L-glutamine, 100IU/ml 160 
penicillin, 100µg/ml streptomycin, and 2.5µg/ml amphotericin. Decidual macrophages were 161 
cultured in decidual macrophage medium: Phenol Red Free RPMI 1640 supplemented with 162 
10% (v/v) FBS, containing 2mmol/L L-glutamine, 100IU/ml penicillin, 100 µg/ml 163 
streptomycin, and 2.5µg/ml amphotericin.   164 
2.5. Re-decidualisation of DSC  165 
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DSC were re-decidualised once they had reached confluency, after approximately 2-5 days 166 
(James-Allan et al., 2018). The cells were washed with PBS and serum free Hams F10 167 
containing 2mM L-glutamine, penicillin (1 unit/ml)/ streptomycin (100μg/ml) and 168 
amphotericin (2.5μg/ml) containing 1μM medroxyprogesterone17-acetate (MPA; Sigma 169 
Aldrich) (3.86mg/ml) and 0.5mM 8 Bromo-cyclic AMP (cAMP; BioLog Life Science Institute, 170 
Germany) was added. As a vehicle control for MPA, serum free Hams F10 containing 10mM 171 
chloroform (BDH (VWR), Pennsylvania, USA) was added to one plate/flask of DSC. The cells 172 
were incubated for 3 days, after which CM was collected and centrifuged at 3000g for 5 173 
minutes. CM was concentrated 20-fold at 4000g prior to storage at -20°c (VivaSpin Columns, 174 
3000 mol wt. cutoff: Sartorius Stedium, Surrey, UK). Decidualisation was confirmed by 175 
secretion of decidualisation markers IGFBP1 and PRL, as previously described (James-Allan 176 
et al., 2018). These cells are subsequently referred to as re-decidualised DSC (rDSC). 177 
2.6. Effect of rDSC and decidual macrophage CM on CD56+ cell receptor expression and 178 
cytokine secretion  179 
In order to determine whether rDSC or decidual macrophages could affect decidual CD56+ 180 
cell receptor expression or cytokine production, decidual CD56+ cells were isolated and 181 
cultured at 1×106 cells/ml in rDSC or decidual macrophage CM in dNK medium for 6 hours. 182 
The 20-fold concentrated rDSC CM was diluted to 1-fold with dNK medium. 20-fold 183 
concentrated serum free Hams F10 medium containing 1μM MPA and 0.5mM 8 Bromo-cyclic 184 
AMP diluted to 1-fold with dNK medium was used as a control. Decidual macrophage control 185 
consisted of decidual macrophage medium. Half of the cells were collected for flow cytometry 186 
after 6 hours, the other half of the cells were centrifuged and resuspended in dNK medium and 187 
incubated for a further 12 hours, after which the CD56+ cell CM was collected and assessed 188 




2.7. Flow cytometry  191 
Decidual CD56+ cells were resuspended in 1ml PBS and stained with fixable viability dye 192 
eFluor780 (eBioscience, Hatfield, UK) for 30 minutes at 4°C. Cells were centrifuged at 500g 193 
for 5 minutes and resuspended in 600μl FACS buffer (PBS with 0.5% (w/v) BSA, 0.05% (w/v) 194 
sodium azide) and non-specific binding was blocked using 1µg/ml human IgG and 10μl human 195 
FcR binding inhibitor (eBioscience) for 30 minutes at 4°C. After incubation, cells were labelled 196 
for 30 minutes at 4°C with primary antibodies as detailed: mouse anti-human CD56-Alexa 197 
Fluor 488 (100µg/ml, BD Biosciences, NJ, USA), mouse anti-human CD3-PerCP (25µg/ml, 198 
eBioscience), mouse anti-human CD9-PE (6.25µg/ml, BD Biosciences), mouse anti-human 199 
CD69-APC (0.75µg/ml, BD Biosciences), mouse anti-human NKp44-PE (6.25µg/ml, BD 200 
Biosciences), mouse anti-human NKp46-PE (12.5µg/ml, BD Biosciences), mouse anti-human 201 
ILT2-APC (10µg/ml, R&D Sciences), mouse anti-human NK62A-APC (100µg/ml, R&D 202 
Sciences), mouse anti-human NKG2C-APC (50µg/ml, R&D Sciences), mouse anti-human 203 
NKG2D-APC (50µg/ml, R&D Sciences), KIR2DL1/KIR2DS5-PE (25µg/ml, R&D Sciences) 204 
and mouse anti-human KIR2DL2-PE (6.25µg/ml, BD Biosciences). The following isotype 205 
controls were used: mouse IgG1 κ-Alexa Fluor 488 (eBioscience), mouse IgG1 PerCP 206 
(eBioscience), mouse IgG1 PE (R&D Systems), mouse IgG2a κ-PE (eBioscience), IgG1 κ-207 
APC (eBioscience) and mouse IgG2a κ-APC (eBioscience). Cells were centrifuged at 500g for 208 
5 minutes and resuspended in FACS buffer. Flow cytometry was carried out on a LSR II flow 209 
cytometer (BD Biosciences). Analysis was carried out by use of FOWJO software (Tree Star 210 
Inc, Oregon, USA). Histrograms were gated on viable CD56+cells. 211 
 212 
2.8. ELISA  213 
The concentration of IL-6 and IL-8 in decidual CD56+ cell CM was measured using DuoSet 214 
ELISA (R&D Systems) according to manufacturer’s instructions.  215 
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2.9. Statistical analyses  216 
Data was analysed by one-way analysis of variance (ANOVA) with Sidak’s multiple 217 
comparison test or t-test by use of GraphPad Prism (version 6.0, CA, USA). Significance was 218 
accepted at p<0.05. ELISA data was transformed by taking the log of the concentration so that 219 
variance was not significantly different, and a t-test could be performed on the data.    220 
3. Results  221 
3.1. Receptor repertoire of CD56+ cells is not regulated by DSC or decidual macrophage CM  222 
dNK cells have a unique receptor expression profile and have previously been shown to express 223 
the following receptors: CD9, CD69, NKp44, NKp46, ILT2, NKG2A, NKG2C, NKG2D, 224 
KIR2DL1 and KIR2DL2 (Wallace et al., 2015). The effect that DSC and decidual macrophage 225 
secreted factors had on the expression of CD56+ cell receptors was investigated. Isolated first 226 
trimester CD56+ cells were cultured with re-decidualised (rDSC) or decidual macrophage CM 227 
for 6 hours after which receptor expression was assessed by flow cytometry (gating strategy, 228 
Figure 1). Examination of CD56+ cells after 6 hours of culture determined that all receptors 229 
were present on the cells. All receptors were expressed in the same proportion in control-treated 230 
and rDSC CM-treated cells (Figure 2) and in control-treated and decidual macrophage CM-231 
treated cells (Figure 3).   232 
3.2. CD56+ decidual cell cytokine secretion is stimulated by DSC  233 
Decidual NK cells have a secretory function; previous studies have shown that first trimester 234 
dNK cells secrete the chemokines IL-8 and IL-6 (Wallace et al., 2013b). This study examined 235 
if DSC secreted factors have an effect on the secretion of the dNK cytokines IL-8 and IL-6. 236 
CD56+ cells were cultured with rDSC CM for 6 hours after which the media was changed and 237 
CD56+ cell conditioned media was collected after a further 12 hours of culture. Cells treated 238 
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with rDSC CM secreted significantly more IL-8 (Figure 4A) and IL-6 (Figure 4B) than cells 239 
treated with control medium.  240 
3.3. CD56+ decidual cell cytokine secretion is not stimulated by decidual macrophages  241 
To determine if decidual macrophage secreted factors have an effect on the secretion of 242 
cytokines IL-8 and IL-6. CD56+ cells were cultured with decidual macrophage CM for 6 hours 243 
after which the media was changed and dNK conditioned media was collected after a further 244 
12 hours of culture. IL-8 (Figure 5A) or IL-6 (Figure 5B) secretion showed no significant 245 
changes when treated with decidual macrophage CM compared to control.   246 
4. Discussion  247 
During the first trimester of pregnancy, dNK cells are the predominant leukocyte within the 248 
decidua and therefore come in to contact with other decidual cells, such as DSC and 249 
macrophages. dNK cells differ from pbNK cells due to their unique receptor repertoire and 250 
cytokine-secreting phenotype, which dictate their role during early pregnancy, including spiral 251 
artery remodeling and interaction with EVT (Moffett-King, 2002, Smith et al., 2009). In this 252 
study we have demonstrated that secretion of the cytokines IL-8 and IL-6 from first trimester 253 
CD56+ cells is stimulated by first trimester DSC secreted factors, but not secreted factors from 254 
decidual macrophages. This suggests that DSC interact with dNK, influencing their function 255 
and possibly their role during the first trimester of pregnancy.  256 
In the decidua NK cells are known to be in close contact with trophoblast cells. A crucial step 257 
in placentation during early pregnancy is the remodeling of spiral arteries leading to high 258 
volume, low resistance vessels that transport maternal blood to the placenta. Smith and 259 
colleagues demonstrated that this is a multi-step process, which begins with a trophoblast-260 
independent stage in which disruption of vascular smooth muscle cells and the endothelial cell 261 
layer occur in the absence of invading trophoblasts but in the presence of dNK and macrophage 262 
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cells (Smith et al., 2009). The ability of dNK cells to secrete soluble factors has been shown to 263 
induce VSMC disruption prior to EVT interaction with spiral arteries inferring that the factors 264 
that dNK secrete play an important role in spiral artery remodeling. It is also known that factors, 265 
such as IL-8 and CXCL10, secreted by dNK promote invasion and chemotaxis of EVT and 266 
therefore also contribute to the trophoblast-dependent stage of spiral artery remodeling (Hanna 267 
et al., 2006, Wallace et al., 2013a).  268 
Results from this study demonstrate that conditioned media from rDSC stimulate CD56+ 269 
decidual cells to secrete increased amounts of the cytokines IL-8 and IL-6. dNK cells have 270 
previously been shown to secrete an array of factors, including these cytokines (Hanna et al., 271 
2006). It is known that trophoblasts, including EVTs, express the respective receptors CXCR1 272 
and IL-6Rα, suggesting that these dNK-secreted cytokines may act upon trophoblast cells 273 
during the first trimester of pregnancy (Jovanovic and Vicovac, 2009, Jovanovic et al., 2010, 274 
Hanna et al., 2006). IL-8 and IL-6 are chemokines that have been implicated in the invasion of 275 
trophoblast cells in the first trimester of pregnancy, including stimulating migration and 276 
chemotaxis of trophoblast cells (Jovanovic and Vicovac, 2009, Jovanovic et al., 2010). 277 
Consequently, as dNK cells come in to contact with DSC as their number increases during 278 
decidualisation and the first trimester of pregnancy, it is possible that crosstalk between DSC 279 
and dNK stimulate dNK to produce factors that could assist in both trophoblast-independent 280 
and trophoblast-dependent spiral artery remodelling.  281 
It has been shown that alongside dNK cells there are other innate lymphoid cell (ILC) 282 
populations found in the decidua during the early stages of pregnancy. Three populations of 283 
ILCs have been identified, including an ILC1 subset which produce IFNγ and two ILC3 284 
populations, lymphoid tissue inducer (LTi)-like cells and NCR+ILC3 which release IL-17/TNF 285 
and IL22/IL-8, respectively (Vacca et al., 2015). NCR+ILC3 cells contribute to IL-8 production 286 
in the decidua. Although subpopulations of ILCs was not investigated in the CD56+ cells 287 
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isolated in this study it would be interesting to investigate if DSC CM is stimulating specific 288 
cells, such as NCR+ILC3, which is leading to the increase in IL-8 secretion observed.  289 
It is known that there is a large infiltration of NK cells into the decidua during the first trimester 290 
of pregnancy, however the mechanism as to how these cells move into the decidua is still 291 
largely unknown. Possible hypotheses include that they are recruited from the pbNK population 292 
to the decidua where they undergo differentiation (Keskin et al., 2007), or that CD56dimCD16- 293 
pbNK cells migrate to the decidua during pregnancy due to the interaction of cytokines on their 294 
surface and the corresponding receptors expressed on trophoblasts or decidual stromal cells 295 
(Hannan et al., 2006). Others have suggested that dNK cells may differentiate from endometrial 296 
NK (eNK) cells which become differentiated due to local mediators in the decidua when 297 
pregnancy occurs. However, results from this study suggest that DSC secreted factors could be 298 
stimulating dNK cells to secrete chemokines that attract additional NK cells to the decidua. 299 
This supports the idea that there is a feedback mechanism in the decidua in which maternal 300 
DSC and immune cells attract each other to populate the decidua in the first trimester of 301 
pregnancy.  302 
DSC are known to secrete an array of factors including RANTES, IL-8, CXCL10 and IL-15 303 
(Sharma et al., 2016). These factors have a range of functions, including the recruitment, 304 
migration and proliferation of dNK cells. Evidence has shown that DSC express ligands that 305 
act on dNK activating receptors, leading to cytokine, chemokine and angiogenic factor 306 
production (Hanna et al., 2006). RANTES, IL-8 and CXCL10 are chemokines found in the 307 
endometrium, with levels highest during the late secretory phase of the menstrual cycle, 308 
suggesting that they may regulate the recruitment of immune cells to the decidua (Arici et al., 309 
1998, Hornung et al., 1997, Kitaya et al., 2004). IL-15, which is secreted by DSC (Kitaya et 310 
al., 2000, Okada et al., 2000), is known to have activating and proliferative effects on NK cells 311 
(Carson et al., 1994) and has been shown to induce uterine NK cells to secrete an array of 312 
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factors (Cooper et al., 2001, Eriksson et al., 2004) and stimulate their proliferation (Verma et 313 
al., 2000).  314 
Macrophages are the second most abundant leukocyte type in the decidua. Macrophages are 315 
typically classified in to either M1, representing a classical pro-inflammatory, anti-microbial 316 
activation, or M2 an anti-inflammatory phenotype. However, it is thought that decidual 317 
macrophages have a unique phenotype that differs from peripheral blood monocytes as they do 318 
not fit in to the conventional M1/M2 classification, due to having aspects of both an anti- and 319 
a pro-inflammatory phenotype (Houser et al., 2011, Svensson et al., 2011). It is known that 320 
decidual macrophages secrete an array of factors, including the pro-inflammatory cytokines 321 
TNFα and IL-1β and the anti-inflammatory cytokines IL-10 and TGFβ (Houser et al., 2011).  322 
dNK cells and macrophages are in close contact within the decidua, therefore it is likely that 323 
crosstalk between these cells occurs. However, little is known regarding the interaction 324 
between immune cells during pregnancy. There is evidence to suggest that secreted factors 325 
could influence dNK cells, for example TGFβ has been shown to suppress the activation of 326 
dNK subpopulations (Zhang et al 2019). Additionally, some functional regulation has been 327 
shown with macrophages inhibiting NK cell killing of invasive trophoblast cells (Co et al 328 
2013). Therefore, we hypothesised that factors secreted from macrophage cells during the first 329 
trimester of pregnancy will influence the phenotype of dNK cells, including their cytokine 330 
secretion and receptor expression. In contradiction to our hypothesis, and the results from DSC 331 
secreted factors, decidual macrophage secreted factors did not influence dNK IL-6 or IL-8 332 
secretion during the first trimester of pregnancy in this study.  333 
dNK cells express a distinctive panel of activating and inhibitory receptors that differs from 334 
pbNK cells. These receptors are crucial to their interaction with EVT as EVT express a unique 335 
combination of MHC molecules, including HLA-C, HLA-E and HLA-G which interact with 336 
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receptors expressed by dNK cells. The expression of these receptors is induced in the mid-337 
secretory phase of the menstrual cycle, in conjunction with decidualisation, suggesting that the 338 
production of cytokines in the endometrium activates the receptor expression on NK cells 339 
converting them to dNK cells.  340 
We found that the receptors studied were expressed by CD56+ cells isolated from first trimester 341 
pregnancies, however in vitro culture with rDSC or decidual macrophage conditioned media 342 
did not alter their expression. This suggests that DSC or decidual macrophage secreted factors 343 
from early pregnancy do not affect the expression of CD56+ cell receptors investigated in this 344 
study despite both secreting a wide range of factors. However, the cells used in this study were 345 
isolated from the decidua and therefore will have already been in contact with decidual factors 346 
in vivo and it may not be possible to modify these further. It would be interesting to determine 347 
whether NK cells isolated from the endometrium that have not previously been exposed to the 348 
decidual environment would have a different response. 349 
We observed some variation in receptor expression, which could be due to patient variability, 350 
or due to potential subpopulations of CD56+ cells, including ILCs. We have previously shown 351 
that the expression of these receptors on dNK cells does not differ in the first trimester when 352 
pre- and post-10 weeks gestation were compared (Wallace et al 2015), therefore this variation 353 
is unlikely to be due to the gestational range of the samples.  Zhang et al (2017) suggest that 354 
that interactions between trophoblast and dNK cells during the first trimester of pregnancy 355 
supress dNK cell functions by inhibiting the expression of their activating receptor NKG2D 356 
(Zhang et al., 2017). However, this report only observed changes in NKGD2 receptor 357 
expression with direct co-culture of cells, but not with trophoblast conditioned media, which 358 
matches the results in this study, suggesting receptor-ligand interactions rather than soluble 359 
factors having a role in this process. 360 
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Decidualisation transforms endometrial stromal cells in to secretory decidual stromal cells and 361 
we have shown that the secretory products from these cells can influence the phenotype of NK 362 
cells within the decidua in the first trimester of pregnancy. Interestingly decidual macrophage 363 
secretory factors did not have the same effect as DSC cells, suggesting that they may not 364 
interact with NK cells during the early stages of pregnancy and therefore have an alternate 365 
function within the decidua. dNK have been shown to have abnormalities in pregnancies with 366 
impaired spiral artery remodelling, and therefore an increased risk of developing complications 367 
such as pre-eclampsia and intrauterine growth restriction (Fraser et al., 2012, Wallace et al., 368 
2013c, Wallace et al., 2014, Wallace et al., 2015). Therefore, the interaction with DSC within 369 
the decidua in the first trimester of pregnancy is likely to be crucial to induce the unique dNK 370 
phenotype so that normal placentation occurs.  371 
5. Conclusion  372 
In summary, we have found that secreted factors from DSC interact with CD56+ cells 373 
simulating cytokine secretion in the first trimester of pregnancy. These findings suggest that 374 
DSC, but not decidual macrophages, influence the phenotype of NK cells in the decidua in the 375 
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Figure 1. Representative gating strategy of flow cytometry data of isolated decidual lymphocytes. 530 
Freshly isolated cells, at 0hr, were gated on forward (FSC)/side-scatter (SSC) (A), this population was 531 
then gated on viability as assessed by negativity for eFluordye (B), the population of alive cells was 532 
gated for CD56 and CD56bright positivity (C). Data are of a sample, gestational age 10 + 0 weeks. Grey 533 
line indicates IgG control, and darker line indicates antibody to CD56.   534 
Figure 2. Percentage of CD56+ cells positive for receptors after stimulation with rDSC 535 
CM. Isolated cells were cultured with rDSC CM for 6 hours and receptor expression 536 
subsequently assessed by flow cytometry. Data shown as mean ± SEM, paired t-test: not 537 
significant, n=6.  538 
Figure 3. Percentage of CD56+ cells positive for receptors after stimulation with decidual 539 
macrophage CM. Isolated cells were cultured with decidual macrophage (dMØ) CM for 6 540 
hours and receptor expression subsequently assessed by flow cytometry. Data shown as mean 541 
± SEM, paired t-test: not significant, n=10.  542 
Figure 4. Secretion of IL-6 and IL-8 from CD56+ cells treated with rDSC CM. Isolated 543 
cells were cultured with rDSC CM for 6 hours. Secretion of IL-8 and IL-6 was measured by 544 
ELISA in media collected after a further 12 hours of culture with dNK medium. A: Secretion 545 
of IL-8 between control-treated and rDSC-treated cells (n=18). B: Secretion of IL-6 between 546 
control-treated and rDSC-treated cells (n=21). Data was log transformed to ensure equal 547 
variance. Paired t-test, data shown as mean ± SEM, **** p<0.0001, *** p<0.001.   548 
Figure 5.  Secretion of IL-6 and IL-8 from CD56+ cells treated with decidual macrophage 549 
CM. Isolated cells were cultured with decidual macrophage (dMØ) CM for 6 hours. Secretion 550 
of IL-8 and IL-6 was measured by ELISA in media collected after a further 12 hours of culture 551 
with dNK medium. A: Secretion of IL-8 between control-treated and decidual macrophage-552 
treated cells (n=7). B: Secretion of IL-6 between control-treated and decidual macrophage-553 
21 
 
treated cells (n=10). Data was log transformed to ensure equal variance. Paired t-test, data 554 
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